The immunoexpression of EGFR and Her2/neu in oral squamous carcinoma

Romanian Journal of Morphology and Embryology

Volumn 53, Issue 3, 2012, Pages 597-601

  Dragomir, L P ^a   Mǎrgǎritescu, Claudiu ^a   Florescu, Alma ^a   Olimid, A D ^b   Dragomir, Manuela ^a   Popescu, M R ^a  

^a UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

^b UNIVERSITY OF CRAIOVA   (Romania)

Author keywords

EGFR; Her2 neu; Immunohistochemistry; Oral squamous carcinomas

Indexed keywords

EID: 84866998531     PISSN: 12200522     EISSN: 20668279     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Högmo A, Kuylenstierna R, Lindholm J, Munck-Wikland E. Predictive value of malignancy grading systems, DNA content, p53, and angiogenesis for stage I tongue carcinomas, J Clin Pathol, 1999, 52(1):35-40.
2. Smith BD, Haffty BG. Molecular markers as prognostic factors for local recurrence and radioresistance in head and neck squamous cell carcinoma, Radiat Oncol Investig, 1999, 7(3):125-144.
3. Grandis JR, Chakraborty A, Zeng Q, Melhem MF, Tweardy DJ. Downmodulation of TGF-alpha protein expression with antisense oligonucleotides inhibits proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells, J Cell Biochem, 1998, 69(1):55-62.
4. Dassonville O, Formento JL, Francoual M, Ramaioli A, Santini J, Schneider M, Demard F, Milano G. Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer, J Clin Oncol, 1993, 11(10):1873-1878.
5. Horiuchi M. Clinico-pathological predictive indicators in squamous cell carcinoma of the head and neck, Gan To Kagaku Ryoho, 1996, 23(3):257-264.
6. Barnes L, Eveson JW, Reichart P, Sidransky D (eds). Pathology and genetics of head and neck tumours, World Health Organization Classification of Tumors, IARC Press, Lyon, 2005.
7. Laimer K, Spizzo G, Gastl G, Obrist P, Brunhuber T, Fong D, Barbieri V, Jank S, Doppler W, Rasse M, Norer B. High EGFR expression predicts poor prognosis in patients with squamous cell carcinoma of the oral cavity and oropharynx: a TMA-based immunohistochemical analysis, Oral Oncol, 2007, 43(2):193-198.
8. Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A, McShane LM, Paik S, Pegram MD, Perez EA, Press MF, Rhodes A, Sturgeon C, Taube SE, Tubbs R, Vance GH, van de Vijver M, Wheeler TM, Hayes DF; American Society of Clinical Oncology; College of American Pathologists. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer, J Clin Oncol, 2007, 25(1):118-145.
9. Oliveira S, van Bergen en Henegouwen PM, Storm G, Schiffelers RM. Molecular biology of epidermal growth factor receptor inhibition for cancer therapy, Expert Opin Biol Ther, 2006, 6(6):605-617.
10. O-charoenrat P, Rhys-Evans PH, Modjtahedi H, Eccles SA. The role of c-erbB receptors and ligands in head and neck squamous cell carcinoma, Oral Oncol, 2002, 38(7):627-640.
11. Sarkis SA, Abdullah BH, Abdul Majeed BA, Talabani NG. Immunohistochemical expression of epidermal growth factor receptor (EGFR) in oral squamous cell carcinoma in relation to proliferation, apoptosis, angiogenesis and lymphangiogenesis, Head Neck Oncol, 2010, 2:13.
12. Ryott M, Wangsa D, Heselmeyer-Haddad K, Lindholm J, Elmberger G, Auer G, Avall Lundqvist E, Ried T, Munck-Wikland E. EGFR protein overexpression and gene copy number increases in oral tongue squamous cell carcinoma, Eur J Cancer, 2009, 45(9):1700-1708.
13. Vosoughhosseini S, LotfiM, Fakhrjou A, Aghbali A, Moradzadeh M, Sina M, Emamverdizadeh P. Analysis of epidermal growth factor receptor in histopathologically tumor-free surgical margins in patients with oral squamous cell carcinoma, African Journal of Biotechnology, 2012, 11(2):516-520.
14. Bernardes VF, Gleber-Netto FO, Sousa SF, Silva TA, Aguiar MC. Clinical significance of EGFR, Her-2 and EGF in oral squamous cell carcinoma: a case control study, J Exp Clin Cancer Res, 2010, 29:40.
15. Yamada T, Takagi M, Shioda S. Evaluation of epidermal growth factor receptor in squamous cell carcinoma of the oral cavity, Oral Surg Oral Med Oral Pathol, 1992, 73(1):67-70.
16. Ulanovski D, Stern Y, Roizman P, Shpitzer T, Popovtzer A, Feinmesser R. Expression of EGFR and Cerb-B2 as prognostic factors in cancer of the tongue, Oral Oncol, 2004, 40(5):532-537.
17. Kusukawa J, Harada H, Shima I, Sasaguri Y, Kameyama T, Morimatsu M. The significance of epidermal growth factor receptor and matrix met alloproteinase-3 in squamous cell carcinoma of the oral cavity, Eur J Cancer B Oral Oncol, 1996, 32B(4):217-221.
18. Gupta AK, McKenna WG, Weber CN, Feldman MD, Goldsmith JD, Mick R, Machtay M, Rosenthal DI, Bakanauskas VJ, Cerniglia GJ, Bernhard EJ, Weber RS, Muschel RJ. Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction, Clin Cancer Res, 2002, 8(3):885-892.
19. Azria D, Bibeau F, Barbier N, Zouhair A, Lemanski C, Rouanet P, Ychou M, Senesse P, Ozsahin M, Pèlegrin A, Dubois JB, Thèzenas S. Prognostic impact of epidermal growth factor receptor (EGFR) expression on loco-regional recurrence after preoperative radiotherapy in rectal cancer, BMC Cancer, 2005, 5:62.
20. Harari PM. Epidermal growth factor receptor inhibition strategies in oncology, Endocr Relat Cancer, 2004, 11(4): 689-708.
21. Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, Jones CU, Sur R, Raben D, Jassem J, Ove R, Kies MS, Baselga J, Youssoufian H, Amellal N, Rowinsky EK, Ang KK. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck, N Engl J Med, 2006, 354(6):567-578.
22. Khan AJ, King BL, Smith BD, Smith GL, DiGiovanna MP, Carter D, Haffty BG. Characterization of the HER-2/neu oncogene by immunohistochemical and fluorescence in situ hybridization analysis in oral and oropharyngeal squamous cell carcinoma, Clin Cancer Res, 2002, 8(2):540-548.
23. Fong Y, Chou SJ, Hung KF, Wu HT, Kao SY. An investigation of the differential expression of Her2/neu gene expression in normal oral mucosa, epithelial dysplasia, and oral squamous cell carcinoma in Taiwan, J Chin Med Assoc, 2008, 71(3):123-127.